Bone remodeling in type 1 diabetes mellitus
https://doi.org/10.20538/1682-0363-2018-3-115-121
Abstract
The aim of the study is to assess the effect of changes in the body in men and women with type 1 diabetes on the state of bone mineral density and metabolic rate and determine the directionality of changes in serum markers of bone remodeling and bone mineral density in both sexes with this disease.
Materials and methods. Bone mineral density (with (DXA) and serum bone remodeling markers [ALP, P1NP and b-CTx] were measured in 57 women and 41 men with type 1 diabetes (n = 98) and in a group control, consisting of 43 women and 39 men (n = 82).
Results. Analysis of the obtained results showed lower values in all the surveyed areas in patients with diabetes, compared with the control group. It was found that the studied bone formation markers (ALP, P1NP) behave differently; while the P1NP level is significantly reduced in women with T1DM vs control patients (p < 0.001), the level of ALP was comparable between the groups of patients with T1DM and control (p > 0.05). b-CTx showed a significant negative correlation with the T-score of the MIC of the lumbar spine (r = –0.431; p = 0.000).
Conclusions. Based on the results of studying the T-score it was found that in men and women with diabetes, in comparison with the control, the bone density in the vertebrae was reduced. In men with type 1 diabetes changes in the T-score in the spine were found to be less intense than in women.About the Author
S. S. Safarova
Azerbaijan Medical University
Azerbaijan
Azerbaijan
Safarova Sain S. - PhD, Associate Professor, Division of Internal Diseases.
23, Bakihanov Str., AZ1022, Baku
References
1. Liao C.C., Lin C.S., Shih C.C., Yeh C.C., Chang Y.C., Lee Y.W. et al. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-basedretrospective cohort studies. Diabetes Care. 2014; 37: 2246–2252.
2. Jackuliak P., Payer J. Osteoporosis, fractures, and diabetes. Int. J. Endocrinol. 2014; 2014: 820615. DOI: 10.1155/2014/820615.
3. Alzubaidi S.A., Bin Salman A.I., Alguraigari A.A. et al. Systematic review of bone turnover Biochemical markers in diabetes mellitus (DM). International Journal of Healthcare Sciences. 2016; 4: 41–48.
4. Farlay D., Armas L.A., Gineyts E., Akhter M.P., Recker R.R., Boivin G. Nonenzymatic glycation and degree of mineralization are higher in bone from fractured patients with type 1 diabetes mellitus. J. Bone Miner. Res. 2016; 31 (1): 190–195. DOI: 10.1002/jbmr.2607.
5. Rubin M.R. Bone cells and bone turnover in diabetes mellitus. Curr. Osteoporos. Rep. 2015; 13 (3): 186–191. DOI: 10.1007/s11914-015-0265-0.
6. Hough F.S. et al. Mechanisms in endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur. J. Endocrinol. 2016; 174: R127–138. DOI: 10.1530/EJE-15-0820.
7. Alexopoulou O., Jamart J, Devogelaer J.P. et al. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes & amp; Metabolism. 2006; 32 (5): 453–458.
8. Pramojanee S.N., Phimphilai M., Chattipakorn N., Chattipakorn S.C. Possible roles of insulin signaling in osteoblasts. Endocrine Research. 2014; 39 (4): 144–151. DOI: 10.3109/07435800.2013.879168
9. Grebennikova T.A., Belaya Zh. E., Rozhinskaya L.Ya. Epigenetic aspects of osteoporosis. Vestnik Rossiyskoy akademii meditsinskikh nauk. 2015; 70 (5): 541–548 (in Russ.).
10. Yalochkina T.O, Belaya Zh.E, Rozhinskaya L.Ya., Antsiferov M.B., Dzeranova L.K., Mel’nichenko G.A. Bone fractures in type 2 diabetes mellitus: prevalence and risk factors. Sakharny diabet. 2016; 19 (5): 359–365. (in Russ.).
Review
For citations:
Safarova S.S. Bone remodeling in type 1 diabetes mellitus. Bulletin of Siberian Medicine. 2018;17(3):115-121. (In Russ.) https://doi.org/10.20538/1682-0363-2018-3-115-121
Views:
973
Email this article 